Biofrontera (BFRI) Enterprise Value (2020 - 2025)

Biofrontera's Enterprise Value history runs 6 years deep, the most recent figure standing at -$6.4 million for Q4 2025.

• In Q4 2025, Enterprise Value fell 8.41% year-over-year to -$6.4 million; the TTM figure through Dec 2025 stood at -$6.4 million (down 8.41% YoY), while the FY2025 annual figure was -$6.4 million, down 8.41% from the prior year.
• Enterprise Value was -$6.4 million for Q4 2025 at Biofrontera, down from -$3.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1.4 million in Q4 2023 to a low of -$31.9 million in Q2 2022.
• Historically, Enterprise Value has averaged -$11.1 million across 5 years, with a median of -$6.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value tumbled 1518.71% in 2022, then surged 94.88% in 2023.
• A 5-year view of Enterprise Value shows it stood at -$24.5 million in 2021, then decreased by 13.05% to -$27.7 million in 2022, then soared by 94.88% to -$1.4 million in 2023, then slumped by 316.05% to -$5.9 million in 2024, then dropped by 8.41% to -$6.4 million in 2025.
• The last three Enterprise Value figures came in at -$6.4 million (Q4 2025), -$3.4 million (Q3 2025), and -$7.2 million (Q2 2025), per Business Quant data.